10-Q: WEED, Inc. Reports Second Quarter 2024 Results with Ongoing Losses and Focus on Future Growth

WEED, Inc. reported a net loss of $110,953 for the second quarter of 2024, continuing its trend of operating without revenue while focusing on future opportunities in the cannabis and hemp industries.

Summary

• WEED, Inc. reported no revenue for the three and six months ended June 30, 2024, and 2023.
• The company's net loss for the three months ended June 30, 2024, was $110,953, compared to a net loss of $173,443 for the same period in 2023.
• For the six months ended June 30, 2024, the net loss was $281,605, compared to $370,458 for the same period in 2023.
• Operating expenses for the three months ended June 30, 2024, totaled $144,955, while for the six months ended June 30, 2024, they were $315,008.
• The company's cash balance decreased significantly from $290,409 at the end of 2023 to $15,171 as of June 30, 2024.
• The company has an accumulated deficit of $84,674,168 as of June 30, 2024.
• WEED, Inc. is pursuing various business opportunities in the cannabis and hemp sectors, including cultivation, research, and product development.
• The company is also exploring opportunities in the infused beverage market and luxury resort development.
• WEED, Inc. is dependent on securing additional financing to fund its operations and future plans.

Sentiment

Score: 3

Explanation: The document reveals a company with significant financial challenges, no revenue, and a high burn rate. While there are some positive aspects, such as the decrease in net loss and the pursuit of new opportunities, the overall sentiment is negative due to the company's precarious financial situation and lack of effective controls.

Positives

• The net loss decreased for both the three and six month periods ended June 30, 2024, compared to the same periods in 2023.
• The company received a $35,000 settlement fund, providing a small boost to its financials.
• WEED, Inc. is actively pursuing various business opportunities in the cannabis and hemp sectors.
• The company is exploring innovative projects such as a luxury cannabis-friendly resort.

Negatives

• The company has not generated any revenue since its inception.
• The company's cash balance has significantly decreased, raising concerns about its ability to fund operations.
• The company has a substantial accumulated deficit of $84,674,168.
• The company's monthly cash burn rate is approximately $46,000.
• The company's disclosure controls and procedures were deemed not effective as of June 30, 2024.
• The company does not have formal processes for identifying and approving related party transactions.

Risks

• The company's ability to continue as a going concern is dependent on securing additional financing.
• The company has no revenue and is incurring significant operating losses.
• The company's cash balance is very low, and it is burning through cash at a rate of approximately $46,000 per month.
• The company's disclosure controls and procedures are not effective, which could lead to inaccurate financial reporting.
• The company does not have an audit committee, which could increase the risk of financial irregularities.
• The company is subject to legal proceedings and claims, which could have a material adverse effect on its financial condition.
• The company is dependent on related party loans, which may not be sustainable in the long term.

Future Outlook

The company plans to pursue various business opportunities in the cannabis and hemp sectors, including cultivation, research, and product development, and is exploring opportunities in the infused beverage market and luxury resort development. The company will need additional financing to attempt to accomplish these goals.

Management Comments

• Management is actively pursuing new products and services to begin generating revenues.
• The Company is currently seeking additional sources of capital to fund short term operations.
• Management believes it is more likely than not that the net deferred tax assets will not be fully realizable.

Industry Context

The company is operating in the emerging cannabis and hemp market, which is characterized by rapid growth and evolving regulations. The company's focus on research, product development, and real estate options aligns with industry trends, but it faces significant competition and financial challenges.

Comparison to Industry Standards

• Many cannabis companies are experiencing losses in the early stages of development, but WEED, Inc.'s lack of revenue is a significant concern.
• Compared to other companies in the sector, WEED, Inc. has a very low cash balance and a high burn rate.
• The company's reliance on related party loans is not uncommon in early-stage companies, but it is not a sustainable long-term strategy.
• The company's lack of effective disclosure controls and procedures is a significant weakness compared to industry best practices.
• Other companies in the sector are actively generating revenue, while WEED, Inc. has not yet commenced sales.

Legal Proceedings

• The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business.

Related Party Transactions

• The company has received short term loans from officers and directors.
• The company has a total of $123,200 of notes payable to related parties as of June 30, 2024.
• Nicole M. Breen receives $1,500 a week in cash compensation for her services.
• Glenn E. Martin receives $8,000 a month in cash compensation for his services.
• A total of $139,500 of officer compensation was unpaid and outstanding at June 30, 2024.

Stakeholder Impact

• Shareholders are at risk due to the company's ongoing losses and need for additional financing.
• Employees may be impacted by the company's financial instability.
• Customers and suppliers are not currently impacted as the company has no revenue.

Next Steps

• The company plans to research and possibly enter the hemp and infused beverage industry.
• The company plans to conduct Sangre's Cannabis Genomic Study.
• The company plans to process the results of the Cannabis Genomic Study.
• The company will look for opportunities to conduct future research, marketing, import and exporting, and manufacturing of any proprietary products on an international level.
• The company will need to raise additional capital to fund its operations and future plans.

Key Dates

Keywords

cannabis, hemp, genomics, cultivation, research, product development, financial results, operating loss, cash flow, related party transactions, disclosure controls, going concern